What is Harrow's cash & equivalents?

Harrow (HROW) reported cash & equivalents of $94.64M in Q1 2026.

How has Harrow's cash & equivalents changed year-over-year?

Harrow's cash & equivalents increased by 41.8% year-over-year, from $66.73M to $94.64M.

What is the long-term trend for Harrow's cash & equivalents?

Over 5 years (2020 to 2025), Harrow's cash & equivalents has grown at a 76.1% compound annual growth rate (CAGR), from $4.3M to $72.93M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Harrow HROW Cash & Equivalents

Cash & Equivalents at other companies

AbbVieABBV

$9.39B+81.5%

Bausch + LombBLCO

$279M+29.8%

Ocular TherapeutixOCUL

$666.7M+90.7%

ViatrisVTRS

$1.81B+139%

Bausch Health CompaniesBHC

$1.31B+13.4%

Tarsus Pharmaceuticals, Inc.TARS

$104.19M-41.6%

Other financials

Income statement

See full

Revenue$44.2M-7.6%

Gross profit$27.0M-16.3%

Operating income-$22.1M-96.6%

Net income-$27.6M-55.2%

EPS (diluted)-$0.74-48.0%

Balance sheet

See full

Total debt$308.6M-32.9%

Total equity$28.7M-49.1%

Total assets$419.5M+15.2%

Cash flow

See full

Operating cash flow-$9.0M-146%

CapEx$194.0K+14.1%

Free cash flow-$9.2M-147%

Valuation

See full

Market cap$1.59B+38.4%

Enterprise value$1.81B+13.8%

P/S5.9×+0.5×

Profitability

See full

Gross margin74.1%-0.4pp

Operating margin7.3%+5.2pp

Net margin-19.8%+18.0pp

FCF margin5.7%+5.0pp

Returns & leverage

See full

Return on equity-50%+17.5pp

Debt / equity10.7×+2.6×

Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Harrow's cash & equivalents?: Harrow (HROW) reported cash & equivalents of $94.64M in Q1 2026.
How has Harrow's cash & equivalents changed year-over-year?: Harrow's cash & equivalents increased by 41.8% year-over-year, from $66.73M to $94.64M.
What is the long-term trend for Harrow's cash & equivalents?: Over 5 years (2020 to 2025), Harrow's cash & equivalents has grown at a 76.1% compound annual growth rate (CAGR), from $4.3M to $72.93M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.